CYP1A2 and breast cancer: The current findings are inconsistent with studies conducted in Hawaii that described lower percent densities [10] and estrogen levels [15] in premenopausal carriers of the C allele, as well as a lower breast cancer risk among postmenopausal women with at least one C allele for CYP1A2*1F [18].